The invention relates to new solid pharmaceutical compositions comprising theangiotensin II receptor antagonist telmisartan, a basic agent, a surfactant oremulsifier and a water-soluble diluent, e.g. in form of granules or in form ofa powder, as well as solid oral formulations ready for use/ingestion, e.g.capsule and tablet formulations made from said pharmaceutical compositions,and methods for producing said compositions and formulations making use of afluid-bed granulation process or of a spray-drying process.
